101 |
METHODS OF PRODUCING MOGROSIDES AND COMPOSITIONS COMPRISING SAME AND USES THEREOF |
EP15839739 |
2015-09-10 |
EP3191584A4 |
2018-07-18 |
ITKIN MAXIM; DAVIDOVICH-RIKANATI RACHEL; COHEN SHAHAR; PORTNOY VITALY; DORON-FAIGENBOIM ADI; PETREIKOV MARINA; SHEN SHMUEL; TADMOR YAAKOV; BURGER YOSEF; LEWINSOHN EFRAIM; KATZIR NURIT; SCHAFFER ARTHUR A; OREN ELAD |
Isolated mogroside and mogrol biosynthetic pathway enzyme polypeptides useful in mogroside biosynthesis are provided. Mogroside biosynthetic pathway enzymes of the invention include squalene epoxidase (SE), expoxy hydratase (EH), cytochrome p450 (Cyp), cucurbitadienol synthase (CDS) and udp-glucosyl-transferase (UGT). Also provided are methods of producing a mogroside using the isolated mogroside and mogrol biosynthetic enzyme polypeptides, the methods comprising contacting a mogrol and/or a glycosylated mogrol (mogroside) with at least one UDP glucose glucosyl transferase (UGT) enzyme polypeptide of the invention catalyzing glucosylation of the mogrol and/or the glucosylated mogrol to produce a mogroside with an additional glucosyl moietie(s), thereby producing the mogroside. Alternatively or additionally provided is a method of synthesizing a mogrol, the method comprising contacting a mogrol precursor substrate with one or more mogrol biosynthetic pathway enzyme polypeptides as described herein catalyzing mogrol synthesis from the mogrol precursor substrate, thereby synthesizing the mogrol. |
102 |
VINYLISOMERASE-DEHYDRATASES, ALKENOL DEHYDRATASES, LINALOOL DEHYDRATASES AND/ CROTYL ALCOHOL DEHYDRATASES AND METHODS FOR MAKING AND USING THEM |
EP16804082 |
2016-05-26 |
EP3303421A1 |
2018-04-11 |
CULLER STEPHANIE J; HASELBECK ROBERT J; NAGARAJAN HARISH; GOUVEA IURI ESTRADA; KOCH DANIEL JOHANNES; LOPES MATEUS SCHREINER GARCEZ; PARIZZI LUCAS PEDERSEN |
In alternative embodiments, provided are non-natural or genetically engineered vinylisomerase-dehydratase enzymes, including alkenol dehydratases, linalool dehydratases and crotyl alcohol dehydratases. In alternative embodiments, provided are non-natural or genetically engineered polypeptides having an activity comprising, for example, a vinylisomerase-dehydratase, an alkenol dehydratase, a linalool dehydratase and/or a crotyl alcohol dehydratase activity, or a combination thereof. In alternative embodiments, also provided are non-natural or genetically engineered nucleic acids (polynucleotides) encoding polypeptides described herein, expression or cloning vehicles comprising or having contained therein nucleic acids as described herein, and non-natural or genetically engineered cells comprising or having contained therein nucleic acids as described herein. In alternative embodiments, also provided are are methods for making various organic compounds, including methyl vinyl carbinol and butadiene. |
103 |
METHODS OF PRODUCING MOGROSIDES AND COMPOSITIONS COMPRISING SAME AND USES THEREOF |
EP15839739.8 |
2015-09-10 |
EP3191584A1 |
2017-07-19 |
ITKIN, Maxim; DAVIDOVICH-RIKANATI, Rachel; COHEN, Shahar; PORTNOY, Vitaly; DORON-FAIGENBOIM, Adi; PETREIKOV, Marina; SHEN, Shmuel; TADMOR, Yaakov; BURGER, Yosef; LEWINSOHN, Efraim; KATZIR, Nurit; SCHAFFER, Arthur A.; OREN, Elad |
Isolated mogroside and mogrol biosynthetic pathway enzyme polypeptides useful in mogroside biosynthesis are provided. Mogroside biosynthetic pathway enzymes of the invention include squalene epoxidase (SE), expoxy hydratase (EH), cytochrome p450 (Cyp), cucurbitadienol synthase (CDS) and udp-glucosyl-transferase (UGT). Also provided are methods of producing a mogroside using the isolated mogroside and mogrol biosynthetic enzyme polypeptides, the methods comprising contacting a mogrol and/or a glycosylated mogrol (mogroside) with at least one UDP glucose glucosyl transferase (UGT) enzyme polypeptide of the invention catalyzing glucosylation of the mogrol and/or the glucosylated mogrol to produce a mogroside with an additional glucosyl moietie(s), thereby producing the mogroside. Alternatively or additionally provided is a method of synthesizing a mogrol, the method comprising contacting a mogrol precursor substrate with one or more mogrol biosynthetic pathway enzyme polypeptides as described herein catalyzing mogrol synthesis from the mogrol precursor substrate, thereby synthesizing the mogrol. |
104 |
MICROORGANISMS AND METHODS FOR ENHANCING THE AVAILABILITY OF REDUCING EQUIVALENTS IN THE PRESENCE OF METHANOL, AND FOR PRODUCING 1,4-BUTANEDIOL RELATED THERETO |
EP13832246 |
2013-08-27 |
EP2888369A4 |
2016-08-10 |
BURGARD ANTHONY P; OSTERHOUT ROBIN E; VAN DIEN STEPHEN J; TRACEWELL CARA ANN; PHARKYA PRITI; ANDRAE STEFAN |
Provided herein is a non-naturally occurring microbial organism having a methanol metabolic pathway that can enhance the availability of reducing equivalents in the presence of methanol. Such reducing equivalents can be used to increase the product yield of organic compounds produced by the microbial organism, such as 1,4-butanediol (BDO). Also provided herein are methods for using such an organism to produce BDO. |
105 |
PATHWAYS TO ADIPATE SEMIALDEHYDE AND OTHER ORGANIC PRODUCTS |
EP13773490.1 |
2013-09-20 |
EP2898082A1 |
2015-07-29 |
LAU, Man, Kit; MERCOGLIANO, Christopher, P. |
Recombinant microorganisms comprising at least one exogenous nucleic acid sequence and capable of producing adipate semialdehyde are provided. Adipate semialdehyde may be produced in a synthesis pathway utilizing a single thiolase reaction. Adipate semialdehyde may also be produced from intermediates consisting of alpha, omega difunctional aliphatic organic molecules. Methods of using recombinant microorganisms to produce 6-aminocaproic acid, adipic acid, hexamethylenediamine and 1.6-hexanediol are also provided. |
106 |
MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF P-TOLUATE AND TEREPHTHALATE |
EP11737470 |
2011-01-21 |
EP2529011A4 |
2015-07-15 |
OSTERHOUT ROBIN E |
|
107 |
AN EXPRESSION CONSTRUCT FOR SENSING CELL DENSITY AND SUBSTRATE AVAILABILITY AND ITS USE IN CONVERSION OF HYDROXYCINNAMIC ACIDS |
EP13807048.7 |
2013-06-12 |
EP2877582A1 |
2015-06-03 |
CHANG, Matthew Wook; LO, Tat Ming Samuel; POH, Chueh Loo |
An Expression system; isolated nucleic acid molecule or host cell comprising: (i) A first gene encoding for a first enzyme linked to a first promoter, wherein the first promoter is a time delay promoter; (ii) A second gene encoding for a second enzyme capable of using the product generated by the first enzyme as a substrate, wherein the second gene is operably linked to a second promoter, wherein the second promoter is inducible by the product generated by the first enzyme; (iii) Optionally, a third gene encoding a transcription factor that represses expression of the second gene in the absence of the product generated by the first enzyme, wherein the third gene is operably linked to a third promoter that regulates expression of the third gene; and its use in producing a product such as hydroxybenzaldehyde. |
108 |
METHODS OF PRODUCING FOUR CARBON MOLECULES |
EP12731825.1 |
2012-06-15 |
EP2721164A2 |
2014-04-23 |
PEARLMAN, Paul, S.; CHEN, Changlin; BOTES, Adriana, L. |
Disclosed are methods for producing butadiene from one or more of several diverse feedstocks including bioderived feedstocks, renewable feedstocks, petrochemical feedstocks and natural gas. |
109 |
ORGANISMS FOR THE PRODUCTION OF 1,3-BUTANEDIOL |
EP10770464 |
2010-04-30 |
EP2424975A4 |
2013-05-29 |
BURGARD ANTHONY P; BURK MARK J; OSTERHOUT ROBIN E; PHARKYA PRITI |
|
110 |
POLYUNSATURATED FATTY ACID SYNTHASE NUCLEIC ACID MOLECULES AND POLYPEPTIDES, COMPOSITIONS, AND METHODS OF MAKING AND USES THEREOF |
EP10754185 |
2010-03-19 |
EP2408797A4 |
2013-01-09 |
APT KIRK E; RICHTER LESLIE; SIMPSON DAVID; ZIRKLE ROSS |
|
111 |
ORGANISMS FOR THE PRODUCTION OF 1,3-BUTANEDIOL |
EP10770464.5 |
2010-04-30 |
EP2424975A2 |
2012-03-07 |
BURGARD, Anthony, P.; BURK, Mark, J.; OSTERHOUT, Robin, E.; PHARKYA, Priti |
A non-naturally occurring microbial organism includes a microbial organism having a 1,3-butanediol (1,3-BDO) pathway having at least one exogenous nucleic acid encoding a 1,3- BDO pathway enzyme expressed in a sufficient amount to produce 1,3-BDO. The pathway includes an enzyme selected from a 2-amino-4-ketopentanoate (AKP) thiolase, an AKP dehydrogenase, a 2-amino-4-hydroxypentanoate aminotransferase, a 2-amino-4- hydroxypentanoate oxidoreductase (deaminating), a 2-oxo-4-hydroxypentanoate decarboxylase, a 3-hydroxybutyraldehyde reductase, an AKP aminotransferase, an AKP oxidoreductase (deaminating), a 2,4-dioxopentanoate decarboxylase, a 3-oxobutyraldehyde reductase (ketone reducing), a 3-oxobutyraldehyde reductase (aldehyde reducing), a 4-hydroxy-2-butanone reductase, an AKP decarboxylase, a 4-aminobutan-2-one aminotransferase, a 4-aminobutan-2- one oxidoreductase (deaminating), a 4-aminobutan-2-one ammonia-lyase, a butenone hydratase, an AKP ammonia-lyase, an acetylacrylate decarboxylase, an acetoacetyl-CoA reductase (CoA- dependent, aldehyde forming), an acetoacetyl-CoA reductase (CoA-dependent, alcohol forming), an acetoacetyl-CoA reductase (ketone reducing), a 3-hydroxybutyryl-CoA reductase (aldehyde forming), a 3-hydroxybutyryl-CoA reductase (alcohol forming), a 4-hydroxybutyryl- CoA dehydratase, and a crotonase. A method for producing 1,3-BDO, includes culturing such microbial organisms under conditions and for a sufficient period of time to produce 1,3-BDO. |
112 |
POLYPEPTIDES FOR CARBON-CARBON BOND FORMATION AND USES THEREOF |
PCT/US2016061539 |
2016-11-11 |
WO2017083656A8 |
2017-08-03 |
BOTES ADRIANA LEONORA; KADI NADIA |
This document describes polypeptides with dual CoA transferase and β-ketothioiase activities and variants thereof, use of such polypeptides in biosynthetic methods, and non-naturally occurring hosts comprising such polypeptides. |
113 |
NOVEL POLYPEPTIDES AND USES THEREOF |
PCT/US2016019966 |
2016-02-26 |
WO2016138498A3 |
2016-11-24 |
BOTES ADRIANA L; KADI NADIA |
The present disclosure provides novel polypeptides with improved 3-buten-2- ol dehydratase activity, polypeptides with improved linalool dehydratase activity, and polypeptides with catalytic activity in the conversion of 3-methyl-3-buten-2-ol to isoprene. Methods of making and using the polypeptides are also provided. |
114 |
METHODS OF PRODUCING1, 3 - BUTADIENE |
PCT/US2012042757 |
2012-06-15 |
WO2012174439A3 |
2013-05-23 |
PEARLMAN PAUL S; CHEN CHANGLIN; BOTES ADRIANA L |
Disclosed are methods for producing butadiene from one or more of several diverse feedstocks including bioderived feedstocks, renewable feedstocks, petrochemical feedstocks and natural gas. |
115 |
POLYUNSATURATED FATTY ACID SYNTHASE NUCLEIC ACID MOLECULES AND POLYPEPTIDES, COMPOSITIONS, AND METHODS OF MAKING AND USES THEREOF |
PCT/US2010028009 |
2010-03-19 |
WO2010108114A2 |
2010-09-23 |
APT KIRK E; RICHTER LESLIE; SIMPSON DAVID; ZIRKLE ROSS |
The present invention is directed to isolated nucleic acid molecules and polypeptides of thraustochytrid polyunsaturated fatty acid (PUFA) synthases involved in the production of PUFAs, including PUFAs enriched in docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), or a combination thereof. The present invention is directed to vectors and host cells comprising the nucleic acid molecules, polypeptides encoded by the nucleic acid molecules, compositions comprising the nucleic acid molecules or polypeptides, and methods of making and uses thereof. |
116 |
MICROORGANISMS FOR THE PRODUCTION OF ADIPIC ACID AND OTHER COMPOUNDS |
PCT/US2009038663 |
2009-03-27 |
WO2009151728A3 |
2010-05-27 |
BURGARD ANTHONY P; PHARKYA PRITI; OSTERHOUT ROBIN E |
The invention provides a non-naturally occurring microbial organism having an adipate, 6-aminocaproic acid or caprolactam pathway. The microbial organism contains at least one exogenous nucleic acid encoding an enzyme in the respective adipate, 6-aminocaproic acid or caprolactam pathway. The invention additionally provides a method for producing adipate, 6- aminocaproic acid or caprolactam. The method can include culturing an adipate, 6-aminocaproic acid or caprolactam producing microbial organism, where the microbial organism expresses at least one exogenous nucleic acid encoding an adipate, 6-aminocaproic acid or caprolactam pathway enzyme in a sufficient amount to produce the respective product, under conditions and for a sufficient period of time to produce adipate, 6-aminocaproic acid or caprolactam. |